tiprankstipranks
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market
Holding SYRE?
Track your performance easily

Spyre Therapeutics (SYRE) Technical Analysis

426 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Spyre Therapeutics’s (SYRE) Moving Averages Convergence Divergence (MACD) indicator is -1.42, suggesting Spyre Therapeutics is a Buy.
Spyre Therapeutics’s (SYRE) 20-Day exponential moving average is 30.25, while Spyre Therapeutics’s (SYRE) share price is $28.43, making it a Sell.
Spyre Therapeutics’s (SYRE) 50-Day exponential moving average is 30.77, while Spyre Therapeutics’s (SYRE) share price is $28.43, making it a Sell.

Spyre Therapeutics (SYRE) Pivot Points

Dec 20, 2024, 11:03 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
26.25
26.74
27.24
27.74
28.24
28.73
29.24
Fibonacci
26.74
27.12
27.35
27.74
28.12
28.35
28.73
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Spyre Therapeutics (SYRE) Moving Averages

Dec 20, 2024, 11:03 PM
Period
Simple
Exponential
MA5
27.90Buy
28.07Buy
MA10
27.88Buy
28.84Sell
MA20
31.90Sell
30.25Sell
MA50
31.12Sell
30.77Sell
MA100
29.54Sell
30.27Sell
MA200
31.40Sell
29.92Sell
Spyre Therapeutics’s (SYRE) 10-Day exponential moving average is 28.84, while Spyre Therapeutics’s (SYRE) share price is $28.43, making it a Sell.
Spyre Therapeutics’s (SYRE) 100-Day exponential moving average is 30.27, while Spyre Therapeutics’s (SYRE) share price is $28.43, making it a Sell.
Spyre Therapeutics’s (SYRE) stock price is $28.43 and Spyre Therapeutics’s (SYRE) 50-day simple moving average is 31.12, creating a Sell signal.
Spyre Therapeutics’s (SYRE) stock price is $28.43 and Spyre Therapeutics’s (SYRE) 100-day simple moving average is 29.54, creating a Sell signal.
Spyre Therapeutics’s (SYRE) stock price is $28.43 and Spyre Therapeutics’s (SYRE) 200-day simple moving average is 31.40, creating a Sell signal.

Spyre Therapeutics (SYRE) Technical Indicators

Dec 20, 2024, 11:03 PM
Name
Value
Implied Action
RSI (14)
40.56
Neutral
STOCH (9,6)
40.45
Neutral
STOCHRSI (14)
15.59
Buy
MACD (12,26)
-1.42
Buy
ADX (14)
31.91
Neutral
Williams %R
-81.47
Buy
CCI (14)
-62.70
Neutral
ATR (14)
1.98
-
Ultimate Oscillator
39.55
Neutral
ROC
-28.17
Sell
Spyre Therapeutics’s (SYRE) Relative Strength Index (RSI) is 40.56, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Trend Strength Indicator (ADX) is 31.91, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Commodity Channel Index (CCI) is -62.70, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Price Rate of Change (ROC) is -28.17, creating a Sell signal.

FAQ

Is SYRE a Buy, Hold, or Sell?
Based on SYRE’s technical indicators, SYRE is a Sell.
    What is SYRE’s RSI (14)?
    SYRE’s RSI (14) is 40.56, which suggests SYRE is a Neutral.
      What is SYRE’s MACD?
      SYRE’s MACD is -1.42, which suggests SYRE is a Buy.
        What is SYRE’s 5-day moving average?
        SYRE’s 5-day moving average is 27.90, which suggests SYRE is a Buy.
          What is SYRE’s 20-day moving average?
          SYRE 20-day moving average is 31.90, which suggests SYRE is a Sell.
            What is SYRE’s 50-day moving average?
            SYRE’s 50-day moving average is 31.12, which suggests SYRE is a Sell.
              What is SYRE’s 200-day moving average?
              SYRE’s 200-day moving average is 31.40, which suggests SYRE is a Sell.
                What is SYRE’s Williams % R (14)?
                SYRE’s Williams % R (14) is -81.47, which suggests SYRE is a Buy.
                  What is SYRE’s CCI (14)?
                  SYRE’s CCI (14) is -62.70, which suggests SYRE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis